114 related articles for article (PubMed ID: 2836769)
1. Estrogen and progestin receptors in an ovarian ependymoma.
Auerbach R; Mittal K; Schwartz PE
Obstet Gynecol; 1988 Jun; 71(6 Pt 2):1043-5. PubMed ID: 2836769
[TBL] [Abstract][Full Text] [Related]
2. Are cytosol estrogen and progestin receptors of prognostic significance in the management of epithelial ovarian cancers?
Schwartz PE; MacLusky N; Merino MJ; Livolsi VA; Kohorn EI; Eisenfeld A
Obstet Gynecol; 1986 Dec; 68(6):751-8. PubMed ID: 3785785
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of estrogen and progestin receptors in ovarian cancer.
Kauppila A; Vierikko P; Kivinen S; Stenbäck F; Vihko R
Obstet Gynecol; 1983 Mar; 61(3):320-6. PubMed ID: 6823373
[TBL] [Abstract][Full Text] [Related]
4. Histopathologic correlations of estrogen and progestin receptor protein in epithelial ovarian carcinomas.
Schwartz PE; Merino MJ; Livolsi VA; Lawrence R; MacLusky N; Eisenfeld A
Obstet Gynecol; 1985 Sep; 66(3):428-33. PubMed ID: 4022502
[TBL] [Abstract][Full Text] [Related]
5. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
[TBL] [Abstract][Full Text] [Related]
6. [The importance of hormone receptor analysis for diagnosis and therapy of gynecologic malignancies].
Gitsch E; Salzer H
Wien Klin Wochenschr; 1983 May; 95(11):385-8. PubMed ID: 6310902
[TBL] [Abstract][Full Text] [Related]
7. Estrogen and progesterone receptor titers in primary epithelial ovarian carcinomas.
Jones LA; Edwards CL; Freedman RS; Tan MT; Gallager HS
Int J Cancer; 1983 Nov; 32(5):567-71. PubMed ID: 6315602
[TBL] [Abstract][Full Text] [Related]
8. Hormone-resistant endometriosis following total abdominal hysterectomy and bilateral salpingo-oophorectomy: correlation with histology and steroid receptor content.
Metzger DA; Lessey BA; Soper JT; McCarty KS; Haney AF
Obstet Gynecol; 1991 Nov; 78(5 Pt 2):946-50. PubMed ID: 1833687
[TBL] [Abstract][Full Text] [Related]
9. [Cytosol receptor levels in malignant and benign ovarian tumors].
Thurzó L; Falkay G; Sas M
Orv Hetil; 1987 Aug; 128(36):1881-4, 1887. PubMed ID: 3658406
[No Abstract] [Full Text] [Related]
10. [Cytoplasmatic receptors of steroid hormones in malignant epithelial ovarian tumors].
Makhova EE; Gershteĭn ES; Smirnova KD; Murav'eva NI; Kuz'mina ZV
Vopr Onkol; 1984; 30(12):36-40. PubMed ID: 6516272
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptors in ovarian epithelial carcinoma.
Schwartz PE; LiVolsi VA; Hildreth N; MacLusky NJ; Naftolin FN; Eisenfeld AJ
Obstet Gynecol; 1982 Feb; 59(2):229-38. PubMed ID: 7078869
[TBL] [Abstract][Full Text] [Related]
12. Endolymphatic stromal myosis: surgical and hormonal therapy for extensive venous recurrence.
Montag TW; Manart FD
Gynecol Oncol; 1989 May; 33(2):255-60. PubMed ID: 2539319
[TBL] [Abstract][Full Text] [Related]
13. Persistence and distribution of estrogen receptor in advanced epithelial ovarian carcinoma after chemotherapy.
Richman CM; Holt JA; Lorincz MA; Herbst AL
Obstet Gynecol; 1985 Feb; 65(2):257-63. PubMed ID: 3969239
[TBL] [Abstract][Full Text] [Related]
14. Steroidal regulation of endometriosis tissue: lack of induction of 17 beta-hydroxysteroid dehydrogenase activity by progesterone, medroxyprogesterone acetate, or danazol.
Vierikko P; Kauppila A; Rönnberg L; Vihko R
Fertil Steril; 1985 Feb; 43(2):218-24. PubMed ID: 2981748
[TBL] [Abstract][Full Text] [Related]
15. Short-term effects of tamoxifen, medroxyprogesterone acetate, and their combination on receptor kinetics and 17 beta-hydroxysteroid dehydrogenase in human endometrium.
Neumannová M; Kauppila A; Kivinen S; Vihko R
Obstet Gynecol; 1985 Nov; 66(5):695-700. PubMed ID: 2997680
[TBL] [Abstract][Full Text] [Related]
16. A study of estrogen and progesterone cytosol receptor concentration in benign and malignant ovarian tumors and a review of malignant ovarian tumors treated with medroxy-progesterone acetate.
Bergqvist A; Kullander S; Thorell J
Acta Obstet Gynecol Scand Suppl; 1981; 101():75-81. PubMed ID: 6946676
[TBL] [Abstract][Full Text] [Related]
17. Steroid receptors and progestinic therapy in ovarian endometrioid carcinoma.
Rendina GM; Donadio C; Giovannini M
Eur J Gynaecol Oncol; 1982; 3(3):241-6. PubMed ID: 6220903
[TBL] [Abstract][Full Text] [Related]
18. Sex steroid receptors in gynecologic cancer.
Hoffman PG; Siiteri PK
Obstet Gynecol; 1980 May; 55(5):648-52. PubMed ID: 6988749
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between estrogen and progestin receptor protein and histopathology in ovarian tumor].
Wang JH; Han SW; Cao ZY; Wang SL; Sun WG
Hua Xi Yi Ke Da Xue Xue Bao; 1988 Sep; 19(3):301-4. PubMed ID: 3253178
[No Abstract] [Full Text] [Related]
20. Ethinyl estradiol and medroxyprogesterone acetate in patients with epithelial ovarian carcinoma: a phase II study.
Freedman RS; Saul PB; Edwards CL; Jolles CJ; Gershenson DM; Jones LA; Atkinson EN; Dana WJ
Cancer Treat Rep; 1986 Mar; 70(3):369-73. PubMed ID: 2937533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
